Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 225 of 5804
-
New hope for myeloma patients who relapse after CAR t: bispecific antibody trial launches
Disease control Not yet recruitingThis is a single-center, single-arm, phase 2 study designed to evaluate the efficacy and safety of linvoseltamab in multiple myeloma (MM) patients who relapsed following BCMA CAR T-cell therapy, whether standard of care or investigational.
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Promising combo targets tough leukemia
Disease control Not yet recruitingB-cell acute lymphoblastic leukemia (B-ALL) is an aggressive blood cancer; about 30% of B-ALL cases in adults have a mutation called BCR-ABL that drives the disease. Blinatumomab is an antibody drug that targets B-ALL cells and helps the immune system to kill them. It is usually…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New weapon against superbug pneumonia and blood infections
Disease control Not yet recruitingThis Phase IIb study aims to evaluate the safety and efficacy of BV100 in combination with low dose polymyxin B plus ceftazidime/avibactam or cefiderocol in patients with suspected or confirmed CRABC infections. The study is divided into two parts (Part A and Part B), recruiting …
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Nasal spray could reverse sudden blindness in groundbreaking trial
Disease control Recruiting nowThis is a phase 3, randomized, multicenter, vehicle-controlled, double-masked study to evaluate the efficacy and safety of intranasal cenegermin compared with vehicle control in adult participants with NAION. Approximately 272 participants who meet all eligibility criteria will b…
Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
One-Time gene shot aims to stop rare nerve disease in kids
Disease control Recruiting nowFirst-in-human Phase 1/2, open-label study to evaluate the safety, tolerability, and efficacy of a single lumbar intrathecal dose of ELP-02 to individuals with CMT4J.
Phase: PHASE1, PHASE2 • Sponsor: Elpida Therapeutics SPC • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Free veggies and cooking classes aim to tame diabetes in pregnancy
Disease control Not yet recruitingNutrition insecurity (inclusive of food insecurity + poor diet quality) is a fundamental social need that must be addressed to improve treatment and health outcomes for high-risk pregnant women with pregestational type 1 and 2 diabetes, poor glucose control, and food insecurity f…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New artificial vein valve could help millions with leg vein disease
Disease control Not yet recruitingA staged prospective, randomized, non-blinded, multicenter study.
Phase: PHASE2, PHASE3 • Sponsor: Hancock Jaffe Laboratiores, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New pill targets hard-to-treat cancers with KRAS G12D mutation
Disease control Not yet recruitingThis study is to evaluate the safety and tolerability of of LT-010391 as monotherapy in participants with KRAS G12D mutant advanced solid tumors
Phase: PHASE1 • Sponsor: Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Tailored drug cocktails aim to outsmart resistant esophageal cancer
Disease control Not yet recruitingThis study is an open-label, biomarker-integrated umbrella trial designed to evaluate the clinical efficacy of molecular subtype- and genomic biomarker-guided precision therapies in patients with advanced esophageal cancer refractory to prior immunotherapy. Conducted in a two-ste…
Phase: PHASE2, PHASE3 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Smart insulin pump could transform hospital diabetes care
Disease control Not yet recruitingAim The investigators aim to investigate if automated insulin delivery systems (AID) improve in-hospital glycemic and clinical outcomes in patients with type 2 diabetes compared to standard-of-care with a pen-basal-bolus insulin regimen manually titrated by general staff at Herl…
Phase: NA • Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment
Disease control Not yet recruitingThe purpose of this study is to find out whether cemiplimab, with or without fianlimab, is an effective treatment for advanced nasopharyngeal carcinoma (NPC), when given with standard chemotherapy drugs gemcitabine and cisplatin before standard chemoradiation.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Liver biopsy during machine perfusion may reveal organ viability before transplant
Knowledge-focused Not yet recruitingLiver transplantation is a life-saving treatment for patients with severe liver disease. Because of the shortage of donor organs, transplant centers increasingly use donor livers that may be more vulnerable to injury and dysfunction. To improve the quality of these organs before …
Phase: NA • Sponsor: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Targeted Antibody-Drug could shrink Hard-to-Treat ovarian cancers
Disease control Not yet recruitingTo observe the efficacy and safety of IMMU-132 in patients with advanced or recurrent ovarian cancer with high TROP-2 expression in tumor tissue, who have failed standard therapy or are unable to receive standard treatment.
Phase: PHASE1 • Sponsor: Shanghai Gynecologic Oncology Group • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
AI could help doctors pick better diabetes drugs
Disease control Not yet recruitingThis study tests whether an artificial intelligence (AI) tool can help doctors choose better diabetes medicines for their patients. Type 2 diabetes is very common, but there are far more patients than diabetes specialists, so many patients are treated by doctors who are not diabe…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AR goggles could help surgeons spot cancer in lymph nodes in real time
Diagnosis Not yet recruitingThis study evaluates how accurately augmented-reality goggles with indocyanine green (ICG) near-infrared fluorescence can identify sentinel (first-draining) lymph nodes during breast cancer surgery. The goggles and ICG signal are used to mark candidate sentinel nodes, and an addi…
Sponsor: Ss. Cyril and Methodius University of Skopje • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Tailored HIIT may boost fitness in stubborn heart failure
Disease control Not yet recruitingCardiovascular-Kidney-Metabolic (CKM) Syndrome is a continuous clinical disease spectrum integrating cardiovascular, renal, and metabolic disorders. Heart failure with preserved ejection fraction (HFpEF) is considered Stage 4 of CKM syndrome, characterized primarily by impairment…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New anesthetic may keep blood pressure steadier during stroke clot removal
Disease control Not yet recruitingEndovascular therapy (EVT) improves the prognosis of patients with acute ischemic stroke (AIS). EVT has been established as a standard of care for AIS caused with large vessel occlusion based on numerous randomized controlled trials. However, despite extensive attention to post-E…
Phase: PHASE4 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Heart drug acoramidis tested for Long-Term cardiac repair in rare amyloidosis
Disease control Not yet recruitingThe study aims to evaluate the effect of acoramidis on cardiac functional and structural improvement in participants with ATTR-CM.
Phase: PHASE4 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can eye games sharpen the mind in schizophrenia?
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether a gamified eye-movement intervention can improve cognitive function in individuals across the schizophrenia spectrum, including clinical high-risk individuals, first-episode schizophrenia patients, and chronic schizophrenia …
Phase: NA • Sponsor: Shanghai Mental Health Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could Pre-Surgery proton beams boost brain tumor outcomes?
Disease control Recruiting nowThe goal of this clinical trial is to learn if preopearative proton therapy (PPT) is tolerable in patients with High-grade brain gliomas. It will also learn about the influence on surgical procedure, clinical effects and safety of regular treatment. The main questions it aims to…
Phase: PHASE1 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC